ABS1022 USE OF CANNABIS LIQUID PLANT EXTRACT 10 mg/ml Δ9-TETRAHYDROCANNABINOL AND 10 mg/ml CANNABIDIOL IN PATIENTS WITH FIBROMYALGIA SYNDROME | Publicación